No phaseRecruitingAge-related condition
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
- Sponsor
- Kuopio University Hospital (Academic or other)
- Enrolment
- 200 planned
- Conditions
- Alzheimer Disease; Frontotemporal Dementia; Dementia With Lewy Bodies
- Interventions
- Gamma tACS (40 Hz) over the superior parietal cortex
- Ages
- adults, older adults
- Registry
- NCT05326750
Full record on ClinicalTrials.gov
From the registry
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Primary outcomes
- Changes in Rey Auditory Verbal Learning Test score
- Changes in Rey Auditory Verbal Learning Test, recognition
- Changes in orientation to time and place (MMSE questions 1-10)
- Changes in Trail Making A & B tests
History
Primary completion expected
Last registry update
Started
Registered